Hans Lee: Excited to Join Sarah Cannon Research Institute as Director of Myeloma Research
Hans Lee, Associate Professor & Director Multiple Myeloma Clinical Research at The University of Texas MD Anderson Cancer Center, shared a post on LinkedIn:
“I am incredibly excited to join Sarah Cannon Research Institute as Director of Myeloma Research and to join SCRI Oncology Partners and Sarah Cannon Cancer Network in Nashville, Tennessee. I look work forward to working together with the phenomenal team at SCRI to accelerate the development AND access to new therapies for myeloma patients through clinical trials across SCRI’s vast network!
I am immensely grateful for a wonderful 14 years at MD Anderson Cancer Center and for all the friendships and collaborations, particularly to my colleagues on the myeloma clinical and research teams, and to my patients for entrusting me with their care.”
“Delighted to welcome my dear friend & colleague, Dr. Hans Lee as our Myeloma leader at Sarah Cannon Research Institute joining as Director of Myeloma Research & SCRI Oncology Partners!
So excited for the impact he’ll make in advancing research & patient care. Welcome to Nashville!”
More posts featuring Sarah Cannon Research Institute.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023